Life sciences
Life sciences
The life sciences and healthcare sectors are evolving rapidly, driven by innovation, new regulations and increasing demands for quality and sustainability. At Forvis Mazars, we work closely with businesses, investors and healthcare providers to deliver confidence in a sector where informed decisions make a significant difference.
We provide audit, tax and advisory services to organisations operating across pharmaceuticals, medical technology, healthcare and social care. Drawing on experience from both the public and private sectors, together with the expertise of our global specialist network, we help our clients achieve sustainable, long-term growth.
What you can expect from us
- Industry specialists with deep understanding of regulatory requirements
- Trusted advice that supports confidence and long-term growth
- Access to international specialist expertise
Let's discuss how we can help create value for your business.
Please visit our global website for Insights
Frequently Asked Questions – Life Sciences
How can advisory services in life sciences and healthcare create business value?
Advisory services in the life sciences and healthcare sectors help organisations respond to changing market conditions, evolving regulatory requirements and technological advances. Through strategic advice, businesses can strengthen their competitive position, improve operational efficiency and create long-term value.
What are the key challenges facing the life sciences sector today?
The life sciences sector is shaped by increasing regulatory requirements, rapid technological innovation, evolving reimbursement models, growing sustainability expectations and intensified competition. At the same time, advances in pharmaceuticals, medical technology and digital health are creating new opportunities for growth and innovation.
How can pharmaceutical and medical technology companies manage regulatory requirements?
To ensure compliance, organisations need effective governance, risk management and internal control processes. With the right framework and specialist support, businesses can reduce regulatory risk and establish a strong foundation for sustainable growth.
How is digitalisation shaping the future of healthcare?
Digitalisation enables more efficient care delivery, improved patient experiences and better use of resources. By implementing the right technologies and digital solutions, healthcare organisations can enhance quality, strengthen operational performance and meet the evolving needs of patients and healthcare systems.
How can healthcare organisations improve operational efficiency and quality?
By analysing processes, resource utilisation and operational performance, organisations can identify opportunities to improve quality, achieve better patient outcomes and increase cost efficiency.
What are sustainable business models in the life sciences sector?
Sustainable business models combine innovation, quality and financial sustainability. They help organisations adapt to changing market conditions, achieve long-term profitability and meet the expectations of investors, customers and regulators.
How can life sciences companies strengthen risk management and internal controls?
Robust risk management and internal control frameworks help organisations identify risks, ensure regulatory compliance and support informed decision-making. They also enhance business resilience and strengthen confidence among external stakeholders.
How are new care models and funding structures transforming the healthcare sector?
New models of care delivery and reimbursement are reshaping the healthcare landscape for both public and private providers. Success requires strategic planning, operational transformation and the ability to respond to evolving expectations around quality, accessibility and cost efficiency.
When is due diligence required in the life sciences and healthcare sectors?
Due diligence is a critical component of investments, mergers and acquisitions, and capital raising. Through financial, operational and regulatory due diligence, organisations and investors can identify risks, opportunities and key value drivers before making significant business decisions.
How can life sciences companies achieve sustainable long-term growth?
Long-term growth depends on innovation, effective operational management, regulatory compliance and the ability to respond to evolving market needs. With the right strategy, organisations can strengthen their competitive advantage and create sustainable value over time.
How do ESG and sustainability requirements affect life sciences companies?
Environmental, Social and Governance (ESG) considerations are becoming increasingly important across the life sciences sector. Investors, customers and regulators are placing greater emphasis on transparency, governance and sustainable business practices. A proactive ESG strategy can help reduce risk while supporting long-term business growth.
How can healthcare and social care organisations future-proof their operations?
By combining digital transformation, workforce planning, effective governance and long-term strategic planning, healthcare and social care organisations can meet growing demand while maintaining high-quality services and long-term financial sustainability.